Home  /  Resource Library  /  Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy

Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy

Study investigated netupitant and palonosetron for prevention of nausea in patients with DLBCL undergoing chemoimmunotherapy.